Long Island, NY
Ropack Pharma Solutions has made the strategic decision to market and sell its solid oral dosage development and manufacturing facility located at 49 Mall Drive, Commack, New York. This state-of-the-art 103,530 sq-ft. facility is located on Long Island, less than 50 miles from New York City and includes process development and commercial manufacturing suites, as well as fully fit-out and equipped analytical laboratories.
This facility has fully validated HVAC’s, USP water system, compressed air, laboratories, warehouses and manufacturing clean rooms from a cGMP standpoint. Complete equipment train and laboratory devices allow the capacity to perform a wide range of cGMP activities from formulation development to mid-sized commercial productions.
RPS has operated in this facility with the belief that advanced technology brings advanced results. We have applied this principle in keeping the labs pristine and production suites equipped and fully commissioned utility systems, with technology from the most respected names in the industry to meet cGMP requirements.
Interested parties should contact Sean McKee, for more information regarding an acquisition of this Commack, New York-based solid dosage development and manufacturing facility.